Emerging Immunotherapies for Parkinson Disease

Emerging Immunotherapies for Parkinson Disease

Abstract Symptomatic treatment options for Parkinson disease have steadily improved, and individualized therapeutic approaches are becoming established for every stage of the disease. However, disease-modifying therapy with a causal approach is still unavailable. The central causative role of alpha-...

Full description

Bibliographic Details
Main Authors: Samis M. A. Zella, Judith Metzdorf, Emine Ciftci, Friederike Ostendorf, Siegfried Muhlack, Ralf Gold, Lars Tönges
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-12-01
Series:Neurology and Therapy
Subjects:
Alpha-synuclein
Antibody-based therapy
Immunotherapy
Neuroinflammation
Parkinson disease
Vaccination
Online Access:http://link.springer.com/article/10.1007/s40120-018-0122-z

Internet

http://link.springer.com/article/10.1007/s40120-018-0122-z

Similar Items